Cours RLS Global AB (publ) Nasdaq Stockholm
Actions
SE0005190725
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Director of Finance/CFO | 64 | 22/08/23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01/01/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/08/12 | |
Director/Board Member | 63 | 01/08/17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01/01/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+30,83 % | 687 Md | |
+30,96 % | 595 Md | |
+0,01 % | 378 Md | |
+15,18 % | 316 Md | |
+11,39 % | 308 Md | |
+0,78 % | 211 Md | |
-6,09 % | 208 Md | |
-2,92 % | 203 Md | |
-3,72 % | 157 Md |